
Journal of Organic Chemistry p. 2445 - 2449 (1986)
Update date:2022-07-30
Topics:
Kumar, Subodh
Agarwal, Nand L.
trans-1,2-Dihydroxy-1,2-dihydrodibenzacridine (5), trans-3,4-dihydroxy-3,4-dihydrodibenzacridine (6), trans-8,9-dihydroxy-8,9-dihydrodibenzacridine (7), 3α,4β-dihydroxy-1α,2α-epoxy-1,2,3,4-tetrahydrodibenzacridine (9), and 3α,4β-dihydroxy-1β,2β-epoxy-1,2,3,4-tetrahydrodibenzacridine (10), which are potentially proximate and ultimate carcinogens of dibenzacridine (1), are synthesized from a common intermediate 8,9,10,11-tetrahydrodibenzacridine (13).The Birch reduction of 13 produced an intermediate which has been used in preparing 5 and 6.However, the bromination of 13 followed by dehydrobromination resulted in a mixture of isomeric alkenes which was successfully converted to 7. 1H NMR, UV, and mass spectra of dibenzacridine derivatives are reported.
View MoreContact:+86+21-58956006 15800617331
Address:402 Room, 150# Cailun Road, Zhangjiang high tech park, Shanghai
Taimai Sanluck Pharmaceutical Co.,Ltd
Contact:86-592-7662921
Address:8D,No.186,Huarong Road,Huli,Xiamen,China
Jinan Trio PharmaTech Co., Ltd
Contact:86-531-88811783;+(0)13153010282
Address:2766 Yingxiu Road, Jinan High-Tech Zone, China
Shanghai Yurui Biotechnology(Anyang) Pharmaceutical Co., Ltd
Contact:+86-0372-3662335 +86-0372-3661988
Address:hanling industrial park anyang
Chengdu Boon Stream Chemical Industry Co.,Ltd.
Contact:+86-28-83156758
Address:No.859,Dongzikou Road,Jinniu District,Chengdu,Sichuan,P.R.China
Doi:10.1016/S0968-0896(99)00047-4
(1999)Doi:10.1002/jlac.198619861009
(1986)Doi:10.1021/acs.joc.6b00472
(2016)Doi:10.1021/ja01560a064
(1957)Doi:10.1021/jacs.8b11942
(2018)Doi:10.1248/cpb.34.523
(1986)